While biologics grab headlines, topical treatments remain a cornerstone of atopic dermatitis management. This post focuses on the new wave of topical innovations, including non-corticosteroid options like topical JAK inhibitors and PDE4 inhibitors. We discuss how these therapies offer effective, steroid-free solutions for mild-to-moderate cases, providing new hope for patients concern... https://www.marketresearchfuture.com/reports/atopic-dermatitis-market-1610